According to the latest data from the Hong Kong Stock Exchange, on February 2, JPMorgan increased its holdings in Innovent Bio (01801) by 1,233,667 shares at a price of HK$78.6975 per share. The total transaction value amounted to approximately HK$97.09 million. Following this acquisition, the firm's total shareholding reached about 87.91 million shares, representing a stake of 5.06%.